IPG Investment Advisors LLC Purchases 11,067 Shares of Tenet Healthcare Corporation $THC

IPG Investment Advisors LLC purchased a new position in shares of Tenet Healthcare Corporation (NYSE:THC) in the 3rd quarter, Holdings Channel reports. The fund purchased 11,067 shares of the company’s stock, valued at approximately $2,828,000.

A number of other large investors have also modified their holdings of the company. Manning & Napier Advisors LLC bought a new stake in Tenet Healthcare in the 2nd quarter valued at about $168,761,000. Arrowstreet Capital Limited Partnership grew its position in Tenet Healthcare by 57.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company’s stock worth $126,757,000 after purchasing an additional 244,901 shares during the last quarter. Bank of New York Mellon Corp bought a new position in Tenet Healthcare in the 2nd quarter worth about $106,342,000. Empowered Funds LLC increased its stake in shares of Tenet Healthcare by 22.1% in the first quarter. Empowered Funds LLC now owns 284,753 shares of the company’s stock valued at $53,736,000 after purchasing an additional 51,549 shares during the period. Finally, First Trust Advisors LP raised its holdings in shares of Tenet Healthcare by 11.8% during the first quarter. First Trust Advisors LP now owns 240,019 shares of the company’s stock valued at $45,294,000 after buying an additional 25,263 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Wall Street Analyst Weigh In

THC has been the subject of several analyst reports. The Goldman Sachs Group reiterated a “buy” rating and set a $305.00 price objective on shares of Tenet Healthcare in a research report on Tuesday, July 28th. Barclays raised their target price on Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a research report on Friday, July 24th. Raymond James Financial reaffirmed an “outperform” rating and set a $285.00 target price on shares of Tenet Healthcare in a research note on Friday, August 14th. Guggenheim reduced their price target on Tenet Healthcare from $307.00 to $306.00 and set a “buy” rating for the company in a research report on Friday, October 30th. Finally, UBS Group increased their price target on Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a research note on Monday, July 27th. Eighteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $290.63.

Insider Activity at Tenet Healthcare

In related news, CEO Saumya Sutaria sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $278.71, for a total value of $13,935,500.00. Following the sale, the chief executive officer directly owned 483,564 shares in the company, valued at $134,774,122.44. The trade was a 9.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Richard J. Mark sold 10,000 shares of the stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $263.42, for a total transaction of $2,634,200.00. Following the sale, the director directly owned 25,121 shares of the company’s stock, valued at approximately $6,617,373.82. This represents a 28.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 105,884 shares of company stock worth $28,740,455. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare News Summary

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Analysts raised their targets and maintained bullish ratings: Truist lifted its target to $305 and reaffirmed “Buy,” KeyCorp raised its target to $300 with an “Overweight” rating, and Leerink Partners, RBC and Wells Fargo also increased targets, to $342, $304 and $321, respectively.
• Positive Sentiment: A report said Tenet raised its 2026 EBITDA outlook following its third-quarter results, a sign of improved expectations for operating performance. Tenet Healthcare stock after Q3: 2026 EBITDA outlook raised
• Negative Sentiment: Guggenheim reportedly trimmed its price target, a counterpoint to the cluster of upward revisions; the provided headline did not specify the revised target or rating. Tenet Healthcare stock gets price target trim from Guggenheim

Tenet Healthcare Trading Down 0.9%

Shares of Tenet Healthcare stock opened at $266.48 on Wednesday. The business has a fifty day simple moving average of $264.37 and a 200-day simple moving average of $221.04. Tenet Healthcare Corporation has a fifty-two week low of $157.58 and a fifty-two week high of $283.05. The firm has a market cap of $21.21 billion, a price-to-earnings ratio of 7.73, a price-to-earnings-growth ratio of 1.44 and a beta of 1.20. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 1.76.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, October 29th. The company reported $6.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.68 by $1.96. Tenet Healthcare had a return on equity of 28.22% and a net margin of 13.09%. The firm had revenue of $6.28 billion for the quarter, compared to analyst estimates of $5.49 billion. During the same period in the previous year, the company earned $3.70 earnings per share. Tenet Healthcare’s revenue was up 6.5% compared to the same quarter last year. On average, equities analysts forecast that Tenet Healthcare Corporation will post 22.31 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.